Establishing an Internal Framework to Prevent Infection and Spread
First written in FY2020. 7 of 9 entries say "Restated". Latest entry: FY2022.
- FY2022RestatedAnnual report
「Under these difficult conditions, the Company continued to work to prevent and contain coronavirus infections,」
The Company continues measures to prevent and contain COVID-19 infections. - FY2022-Q3RestatedAnnual report
「While continuing measures to prevent and contain COVID-19, including remote work and staggered working hours,」
The Company continues measures to prevent and contain infections, including remote work and staggered working hours. - FY2022-Q2RestatedAnnual report
「Under these difficult conditions, the Group continued to prevent and contain COVID-19 while」
The Company continues to prevent and contain COVID-19. - FY2022-Q1RestatedAnnual report
「Under these difficult conditions, the Group continued to prevent and contain COVID-19 while」
The Company continues to prevent and contain COVID-19. - FY2021RestatedAnnual report
「The Group continued to implement measures to prevent and contain COVID-19, including thorough internal infection-control measures, remote work, and staggered working hours. It maintained and used its network environment to facilitate smooth communication inside and outside the Group, thereby continuing its sales, production, and research and development activities.」
The Company continues its sales, production, and research and development activities under infection-control measures through remote work, staggered working hours, and the maintenance and use of its network environment. - FY2021-Q3RestatedAnnual report
「The Group continued to implement measures to prevent and contain COVID-19, including remote work and staggered working hours. While conventional business activities remained restricted, it maintained and used its network environment to facilitate smooth communication inside and outside the Group, thereby continuing its sales, production, and research and development activities.」
The Company continues its sales, production, and research and development activities through infection-control measures such as remote work and staggered working hours, and through the maintenance and use of its network environment. - FY2021-Q2RestatedAnnual report
「Under these difficult conditions, the Group continued to prevent and contain COVID-19 while its conventional business and sales activities remained restricted. By using its network environment to facilitate communication inside and outside the Group, it continued its sales, production, and research and development activities.」
The Company continues its sales, production, and research and development activities using its network environment while maintaining infection-prevention and containment measures. - FY2021-Q1AdvancedAnnual report
「Amid these challenging conditions, the Group has worked to prevent infection and the spread of COVID-19, conducted sales activities via the web and other channels while conventional sales activities were curtailed, and introduced staggered working hours and remote work to give maximum consideration to preventing infection among employees and their families. At the same time, it continued production activities aimed at stable supply and R&D activities for new products.」
The Company states that, in addition to its existing infection-prevention and containment systems, it introduced staggered working hours and remote work to prevent infections among employees and their families. - FY2020First statedAnnual report
「In response to the spread of novel infectious diseases and other infections, the Company collects accurate information and promptly establishes appropriate internal systems for infection prevention and containment.」
As measures to address infectious disease risks, the Company has for the first time specifically described information gathering, infection prevention, containment, and the establishment of internal systems.